ArticleCancers2022

Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism.

Maysa Abu-Khalaf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.